CNBC February 1, 2024
Key Points
– Neurotech startup Synchron is ramping up production of its flagship brain-computer interface to prepare for commercial demand, as the company inches closer to bringing its device to market.
– Synchron, a competitor of Elon Musk’s Neuralink, announced Thursday that it has acquired a minority equity stake in the German manufacturer Acquandas, which has the unique ability to layer the metals that make up one component of the company’s implant.
– Synchron’s BCI allows people with limited physical mobility to operate technology like smart home devices and cursors with their mind.
Neurotech startup Synchron is ramping up production of its flagship brain-computer interface to prepare for commercial demand, as the company inches closer to bringing its...
Today's Sponsors
Today's Sponsor